
In biopharmaceutical process development, the performance and robustness of the virus filtration step are critical factors that influence product safety, manufacturing efficiency, and overall production costs.
- When processing high-concentration antibody solutions, virus filters often face rapid flux decline and insufficient throughput capacity, leading to project delays and rising manufacturing costs.
- During the development of bispecific antibodies or complex recombinant proteins, the lack of reliable performance data can make process development feel like navigating through uncertainty, with many unknown variables.
- At the crucial stage of viral clearance validation, the pressure to pass validation in a single attempt, combined with the potential risk that even small process parameter fluctuations may threaten the safety margin, remains a constant concern.
Against this backdrop, we are pleased to release the Cobetter Viruclear™ Virus Filter Application Guide. More than a product manual, this guide represents a systematic consolidation of our years of hands-on experience—including performance data, validation case studies, and process insights. It is designed to provide practical and actionable technical reference for industry professionals during filtration process design, optimization, and scale-up.
Core Performance Data: A Clear Starting Point for Process Design
Process development begins with clear expectations. In this guide, we disclose for the first time the quantitative performance data of the Viruclear™ series across various typical application scenarios. These data are drawn from extensive internal testing and client cases, aiming to help you quickly build an understanding of the product’s capabilities.

High-concentration products exacerbate concentration polarization and filter cake formation on the membrane surface, limiting the filterable volume. In actual production, it is necessary to strike a balance between the "optimal economic concentration" (volume and mass throughput) and "upstream and downstream process constraints" (e.g., chromatography load, product concentration).
How to choose the right combination of Virus Filters by applications

Viral Clearance Validation: Safety and Robustness
The core mission of virus filters is to ensure safety. This guide presents detailed viral clearance studies against key model viruses such as Minute Virus of Mice (MVM) and Xenotropic Murine Leukemia Virus (X-MuLV). We focus not only on retention under ideal conditions but also on performance under simulated “worst-case” scenarios, including pressure fluctuations, process interruptions, and extreme fouling.

Process Case Studies: Approaches to Solving Real-World Problems
Theoretical data must be complemented by practical experience. The guide includes process optimization case studies from real projects. For example, we detail how adjusting feed concentration effectively improved the filtration performance of a high-concentration antibody, significantly increasing both flux and throughput.

Cobetter virus filtration solutions show good compatibility and throughput for low- to mid-concentration mAb feedstreams (e.g., below 20 g/L). For very high-concentration feeds, direct filtration may reduce performance. During process development, moderate dilution can be considered—if compatible with downstream steps—to optimize overall filtration efficiency.
Selection and Scale-Up: A Complete Application Logic
The right filter selection is the foundation of success. The guide systematically explains how to match pre-filters (e.g., deep-bed PDT or membrane-based PNY) and virus filters (e.g., high-throughput VF series or highly compatible RC series) based on feed characteristics such as protein type, concentration, and impurity levels. We also provide linear scale-up data and logic, showing how lab-scale process parameters can be reliably scaled to production.
Choose the right Viruclear™ VF Filters

Choose the right Viruclear™ RC Filters

Choose the right Viruclear™ Pre-filters

Summary
The ultimate goal of releasing this guide is to give your biopharmaceutical process development more certainty, reliability, and excellence through the choice of Cobetter Viruclear™.
- For process development scientists: It saves significant time on screening and trial-and-error, providing a reliable starting point and clear optimization directions.
- For production and project managers: It helps more accurately assess process costs, supply chain security, and production timelines.
- For quality and regulatory specialists: The rich validation data and scientific insights serve as strong support when communicating with regulatory authorities.